This website is an initiative of J-Lab.

Who's Blogging

Stacey Borden

After working for financial giant Lehman Brothers, Stacey Borden left the finance world to help women across industries, generations and geographies. In addition to working on ChickRx, Borden is also working on her MBA at Harvard Business School.

Meghan Muntean

Currently a portfolio consultant on Wall Street, Muntean graduated magna cum laude from Princeton University in 2006, where she served as Editor-in-Chief of Business Today, the largest college magazine in circulation.

Click for full bios.

Visit ChickRx

Project Blog: ChickRx

Harvard MBA student Stacey Borden and partner Meghan Muntean will lead a team of women in launching an “edgy, approachable, engaging” online health resource uniquely targeted to women, ages 18 to 27. It will have content and Q&As;, updated daily, from medical, family and nutrition experts.

ChickRx Launches

Tuesday, August 17, 2010

San Francisco, CA—, a witty health website for 20-something women, launched in beta today. Distinct in its humorous and relatable tone, the site serves as both a trusted source of expert information and a tongue-in-cheek form of daily entertainment. ChickRx plans to roll out interactive tools and community features after its launch.

Co-founders Stacey Borden and Meghan Muntean, both 26, felt a need for a health website specifically targeting their demographic and identified a void in the market. “The idea for ChickRx came from personal experience,” Borden, CEO, said. “We were frustrated that while there were comprehensive health sites for women of all ages, there was nothing that specifically catered to and understood us—20-something women off on our own, full of health-related concerns and curiosities.” Addressing this void, ChickRx delivers information with a “we get it because we’ve been there” tone, not a mother-knows-best attitude or boring textbook approach. For example, internist Dr. Andrea Ruman describes the telltale symptoms and treatments for irritable bowel syndrome in an “Ask Rxperts” Q&A piece titled “IBS: It Beats Syphilis.”

ChickRx is a DailyCandy-meets-WebMD type of resource addressing health issues that are increasingly discussed among young adult women. The site features expert Q&A, up-to-date news, product picks and celebrity tidbits across the following categories: sex & gynecology, fitness & nutrition, emotional health & relationships, dermatology, and general health.

Borden and Muntean both invested their personal savings in ChickRx. They began laying the groundwork for the company while Borden was an MBA student at Harvard Business School and Muntean was an Assistant Vice President at a Wall Street investment bank. The concept quickly gained traction, winning the 2009 J-Lab New Media Women Entrepreneurs award, out of 435 national entries.

Supported by an angel investor, the ChickRx team consists of the co-founders, health experts, savvy comedic writers and interns at Harvard and Stanford. Borden received her BA from Harvard College and MBA from Harvard Business School; Muntean received her BA from Princeton University.

“I left a stable, lucrative job because I believe in the very real need for ChickRx,” said Muntean, President. “We have zero doubt young adult women need better health information than they’re currently getting. Aside from delivering important info, we want to show our peers that they aren’t alone in their health concerns, and make them laugh at the same time. Who says an expert health site has to be boring?”

ChickRx advisors include Chris Schroeder  (CEO, HealthCentral), Trip Adler and Tikhon Bernstam (Co-Founders, Scribd), Janet Hanson  (Founder, 85 Broads global women’s network), and Susan Kare  (Principal, Susan Kare Design; former Creative Director, Apple). ChickRx is a cutting-edge health website for young adult women that presents reliable expert information with witty, relatable humor. Visit us at:  for more information.

   • Posted by ChickRx on 08/17 at 07:52 AM

Next entry: ChickRx Wins New Media Women Entrepreneur Award

Previous entry: Seed Financing: Done